TP53 and granular cell tumor: In the following report we explore the complex role of TP53 in GCTs cisplatin-resistance mechanisms, going through several recent genomic studies, as well as the potential role of TP53 in determining SCs in GCT patients with SCs, as part of our experience as a Center of reference for both GCTs and cancer predisposing syndromes.